Position in JNJ
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$3,099,957
-$372,557 QoQ
Shares Held
12,206
-14.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.23%
of 13F equity value
Holder Rank
#1,985
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 42%
Shared 0%
None 58%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BOURNE LENT ASSET MANAGEMENT INC holds $19,951,025 across 7 Drug Manufacturers - General names. JNJ ranks #4 (15.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
117,066 | $6,745,342 | |
| 2 | LLY |
ELI LILLY & Co
|
3,887 | $4,662,184 | |
| 3 | AMGN |
Amgen Inc
|
9,860 | $3,570,503 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
12,206 | $3,099,957 | |
| 5 | PFE |
Pfizer Inc
|
36,275 | $873,502 | |
| 6 | MRK |
Merck & Co., Inc.
|
4,357 | $559,874 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,480 | $439,663 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,099,957 | 12,206 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $3,472,514 | 14,206 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $2,908,889 | 14,056 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $2,630,368 | 14,186 | Shares | Sole | 2025-12-15 | |
| 2025-06-30 | $2,173,785 | 14,231 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $2,363,385 | 14,251 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $2,077,610 | 14,366 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $2,295,741 | 14,166 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $2,063,194 | 14,116 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $2,268,602 | 14,341 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $2,247,808 | 14,341 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $2,233,610 | 14,341 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $2,373,722 | 14,341 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $2,242,230 | 14,466 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $2,555,418 | 14,466 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $2,533,060 | 15,506 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $2,752,470 | 15,506 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $2,783,574 | 15,706 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $2,695,378 | 15,756 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $2,544,594 | 15,756 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $2,612,117 | 15,856 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $2,605,933 | 15,856 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $2,485,974 | 15,796 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $2,399,350 | 16,116 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $2,266,393 | 16,116 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $2,113,291 | 16,116 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||